טוען...
Use of Recombinant Factor VIIa (NovoSeven) in Pediatric Cardiac Surgery
Significant post-operative bleeding can be encountered in a small population of pediatric surgical patients requiring cardiopulmonary bypass (CPB). Recombinant factor VIIa (Novo-Seven) has been advocated as a possible off-label rescue therapy for these individuals when conventional blood component t...
שמור ב:
| הוצא לאור ב: | J Extra Corpor Technol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of ExtraCorporeal Technology
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4680713/ https://ncbi.nlm.nih.gov/pubmed/19192753 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|